1. Home
  2. Corporate Information
  3. CEO Message

Corporate Information

CEO Message

PresidentAchieving the corporate mission with the original drug discovery technology”

RaQualia began its operation in July 2008 with a corporate mission, “We seek to bring people health and happiness through innovative new medications.” Thanks to all the support from our stakeholders, RaQualia listed on the JASDAQ Growth Market in July 2011.

RaQualia’s R&D strategy has transformed, and is now based on “selection and concentration.” We now focus on pain and gastrointestinal disease areas targeting ion channels, where our competency lies. In addition, we have made a strategic decision to relocate the discovery functions of RaQualia to Nagoya University in order to better promote a synergy effect with academia.

We continue further efforts to improve the shareholder value as well as to achieve financial stability by promoting licensing activities and alliance management with our corporate partners. We will continue to work tirelessly to deliver innovative medicines that can truly bring happiness to patients and their families.

Thank you very much for all the support to RaQualia.

President Naoki Tani

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Quality Policy
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Press Release
Research & Development
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Potassium-Competitive Acid Blocker
5-HT4 Partial Agonist
5-HT2B Antagonist
Motilin Receptor Agonist
Licensing Status
Shareholder and Investor Information
Vision, Management Principle and Culture
Corporate Governance
Outline of Securities Matters
IR Library
IR Calendar
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release